Open Access Open Access
Restricted Access Subscription Access


Depression is one of the most common affective disorders, and it is the main psychological problem of modern society. Pharmacotherapy and psychotherapy methods are used in medicine as traditional treatment of depressive disorders. However, there is a therapeutic problem of drug resistance, despite the significant progress in understanding neurophysiological mechanisms of depression progression. The neurofeedback is one of alternative therapeutic methods, which makes it possible to activate the ability of self-regulation of the brain by means of every second feedback about changes of bioelectrical activity given in the form of audio and video information. In the article main protocols of neurofeedback method in treatment of patients with depressive disorders are considered and recommendations are given for modernization and improving the efficacy of this method which will make it possible to accelerate processes of rehabilitation of patients suffering with depressive disorders.

T F Shamaeva

FSBSI «Institute of Experimental Medicine»

  1. Хессет Дж. Введение в психологию. М.: Мир, 1981. C. 175-189. [Khesset J. Introduction to psychology. Moscow: World, 1981. Р. 175-189].
  2. Nestoriuc Y., Martin A. Efficacy of biofeedback for migraine: a meta-analysis // Pain. 2007. Vol. 128. P. 111-127.
  3. Yucha C., Clark L., Smith M., Uris P., La Fleur B., Duval S. The Effect of Biofeedback in Hypertension // Applied Nursing Research. 2001. Vol. 14, N 1. P. 29-35.
  4. Moreland J., Thomson M., Fuoco A. Electromyographic biofeedback to improve lower extremity function after stroke: a meta-analysis // Arch. Phys. Med. Rehabil. 1998. Vol. 79. P. 134-140.
  5. Nagai Y., Goldstein L., Fenwick P., Trimble M. Clinical efficacy of galvanic skin response biofeedback training in reducing seizures in adult epilepsy: a preliminary randomized controlled study // Epilepsy & Behavior. 2004. Vol. 56. P. 216-223.
  6. Buzsáki G. Rhythms of the Brain. Long-Term Training of Brain Rhythms. Meditation-Induced Alpha Activity. Oxford: Oxford University Press, 2006. P. 215-230.
  7. Sterman B. Biofeedback in the treatment of epilepsy // Cleveland Clinic Journal of Medicine. 2010. Vol. 77. P. 60-67.
  8. Kouijzer M. van Schie H., de Moor J., Gerrits B., Buitelaar J. Neurofeedback treatment in autism. Preliminary findings in behavioral, cognitive, and neurophysiological functioning // Research in Autism Spectrum Disorders. 2010. Vol. 4. P. 386-399.
  9. Gani C., Birbaumer N., Strehl U. Long term effects after feedback of slow cortical potentials and of theta-beta-amplitudes in children with attention-deficit hyperactivity disorder (ADHD) // International Journal of Bioelectromagnetism. 2008. Vol. 10. P. 209-232.
  10. Peniston E., Kulkosky P. Alpha-theta brainwave neurofeedback therapy for Vietnam veterans with combat-related posttraumatic stress disorder // Medical Psychotherapy: An International Journal. 1991. Vol. 4. P. 47-60.
  11. Baehr E., Rosenfeld J., Baehr R., Earnest C. Clinical Use of an Alpha Asymmetry Neurofeedback Protocol in the Treatment of Mood Disorders. New York: Academic Press, 1999. Р. 182-201.
  12. Hammond D.C. Neurofeedback with anxiety and affective disorders // Child Adolescent Psychiatric Clinics of North America. 2005. Vol. 14. P. 105-123.
  13. Moss D., Gunkelman J. Task force report on methodology and empirically supported treatments: introduction and summary // Applied Psychophysiology and Biofeedback. 2002. Vol. 27, N 4. P. 261-262.
  14. Yucha C., Gilbert C. Evidence-Based Practice in Biofeedback and Neurofeedback // Wheat Rige, CO: AAPB, 2004.
  15. Evans J. Handbook of neurofeedback: dynamics and clinical applications. New York: Haworth Medical Press, 2007. P. 378.
  16. Lopez A., Murray C. The Global Burden of Disease, 1990-2020 // Nature Medicine. 1998. Vol. 4, N 11. P. 1241-1243.
  17. La Vaque T. J., Hammond D. C., Trudeau D., Monastra V., Perry J., Lehrer P., Matheson D., Sherman R. Template for developing guidelines for the evaluation of the clinical efficacy of psychophysiological evaluations // Appl. Psychophysiol. Biofeedback. 2002. Vol. 27, N 4. P. 273-281.
  18. Dias M., Deusen A. A New Neurofeedback Protocol for Depression // The Spanish Journal of Psychology. 2011. Vol. 14, N 1. P. 374-384.
  19. Schaffer C., Davidson R., Saron C. Frontal and parietal electroencephalogram asymmetry in depressed and non-depressed subjects // Biological Psychiatry. 1983. Vol. 18. P. 753-759.
  20. Davidson R., Schaffer C., Saron C. Effects of Lateralized Presentations of Faces on Self-Reports of Emotion and EEG Asymmetry in Depressed and Non-Depressed Subjects // Psychophysiology. 1985. Vol. 22. P. 353-364.
  21. Henriques J., Davidson R. Left Frontal Hypoactivation in Depression // Journal of Abnormal Psychology. 1991. Vol. 100. P. 535-545.
  22. Baehr E., Rosenfeld J., Baehr R., Earnest C. Comparison of two EEG asymmetry indices in depressed patients vs. normal controls // International Journal of Psychophysiology. 1998. Vol. 31. P. 89-92.
  23. Rosenfeld J. An EEG Biofeedback Protocol for Affective Disorders // Clinical Electroencephalography. 2000. Vol. 31. P. 7-12.
  24. Rosenfeld J., Cha G., Blair T., Gotlib I. Operant (Biofeedback) Control of Left-Right Frontal Alpha Power Differences: Potential Neurotherapy for Affective Disorders // Biofeedback and Self-Regulation. 1995. Vol. 20. P. 241-258.
  25. Baehr E., Rosenfeld J., Baehr R. The Clinical Use of An Alpha Asymmetry Protocol in the Neurofeedback Treatment of Depression: Two Case Studies // Journal of Neurotherapy. 1997. Vol. 2. P. 10-23.
  26. Baehr E., Rosenfeld J., Baehr R. Clinical Use of an Alpha Asymmetry Neurofeedback Protocol in the Treatment of Mood Disorders // Journal of Neurotherapy. 2001. Vol. 4. P. 11-18.
  27. Choi S., Chi S., Chung S., Kim J., Ahn C., Kim H. Is alpha wave neurofeedback effective with randomized clinical trials in depression? A pilot study // Neuropsychobiology. 2011. Vol. 63, N 1. P. 43-51.
  28. Gruzelier J., Egner T. Critical validation studies of neurofeedback // Child Adolesc Psychiatric Clinics N. Am. 2005. Vol. 14. P. 83-104.
  29. Michael A., Krishnaswamy S., Mohamed J. An open label study of the use of EEG biofeedback using beta training to reduce anxiety for patients with cardiac events // Neuropsychiatry Dis Treat. 2005. Vol. 1, N 4. P. 357-363.
  30. Rotenberg V. The peculiarity of the right-hemisphere function in depression: solving the paradoxes // Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2004. Vol. 28. P. 1-13.
  31. Davidson R. Affective Style and Affective Disorders: Perspectives from Affective Neuroscience // Cognition and Emotion. 1998. Vol. 12, N 3. P. 307-330.
  32. Hammond C. Neurofeedback Treatment of Depression with the Roshi // Journal of Neurotherapy. 2000. Vol. 4, N 2. P. 45-56.
  33. Begić D., Mahnik-Miloš M., Grubišin J. EEG characteristics in depression, „negative“ and „positive“ schizophrenia // Psychiatria Danubina. 2009. Vol. 21, N 4. P. 579-584.
  34. Grin-Yatsenko V., Baas I., Ponomarev V. et al. EEG power spectra at early stages of depressive disorders // Journal of clinical neurophysiology. 2009. Vol. 26. P. 401-406.
  35. Hughes J., John E. Conventional and quantitative electroencephalography in psychiatry // J. Neuropsychiatry Clin. Neurosci. 1999. Vol. 11, N 2. P. 190-208.
  36. Peniston E., Kulkosky P. Alpha-theta brainwave training and beta endorphin levels in alcoholics // Alcoholism: Clinical and Experimental Results. 1989. Vol. 13, N 2. P. 271-279.
  37. Fahrion S. Group biobehavioral treatment of addiction // Paper presented at the 4th Meeting on the Neurobiology of Criminal and Violent Behavior. Research and Clinical Applications of Neurofeedback for Offender Populations with Substance Use Disorders. 2002.
  38. Sokhadze T., Cannon R., Trudeau D. EEG Biofeedback as a Treatment for Substance Use Disorders: Review, Rating of Efficacy, and Recommendations for Further Research // Applied Psychophysiological Biofeedback. 2008. Vol. 33, N 1. P. 1-28.
  39. Neurofeedback and Biofeedback for Post-Traumatic Stress Disorder, Generalized Anxiety Disorder, and Depression: A Review of the Clinical Evidence and Guidelines. Rapid Response. Summary with Critical Appraisal: June 15, 2012. Электронный ресурс (дата обращения 23.10.2017).
  40. Bhat P. Efficacy of Alfa EEG wave biofeedback in the management of anxiety // Ind. Psychiatry J. 2010. Vol. 19, N 2. P. 111-114.
  41. Saldanha D., Chaudhury S., Pawar A., Ryali V., Srivastava K. Reduction in Drug Prescription using Biofeedback Relaxation in Neurotic and Psychosomatic Disorders // Med. J. Armed. Forces India. 2007. Vol. 63, N 4. P. 315-317.
  42. Neurofeedback and Biofeedback for Mood and Anxiety Disorders: A Review of the Clinical Evidence and Guidelines - An Update. Rapid Response. Summary with Critical Appraisal: August 26, 2014. Электронный ресурс (дата обращения 23.10.2017)
  43. Cheon E., Koo B., Seo W., Lee J., Choi J., Song S. Effects of neurofeedback on adult patients with psychiatric disorders in a naturalistic setting // Appl. Psychophysiol. Biofeedback. 2015. Vol. 40, N 1. P. 17-24.
  44. Cheon E., Koo B., Choi J. The Efficacy of Neurofeedback in Patients with Major Depressive Disorder: An Open Labeled Prospective Study // Appl. Psychophysiol. Biofeedback. 2016. Vol. 41, N 1. P. 103-110.
  45. Hammond C. The effects of caffeine on the Brain. A review // Journal of Neurotherapy. 2003. Vol. 7, N 2. P. 79-89.
  46. Бойцова Ю. Влияние кофеина и феназепама на количественные характеристики ЭЭГ и сверхмедленных фазических электрических процессов мозга // Физиология человека. 2007. Т. 33, № 3. С. 1-3 [Boytsova Yu. Effect of caffeine and phenazepam on the quantitative characteristics of the EEG and the ultra-slow phasic electrical processes of the brain, Human Physiology. 2007. Vol. 33, N 3. Р. 1-3.]
  47. Бельских И.А., Голубев С.А., Козаренко Л.А., Плотников Д.В. Гендерные различия структуры общемозговых индексов фоновой ЭЭГ человека // Курский научно-практический вестник «Человек и его здоровье». 2011. № 2. С. 5-8. [Bel'skikh I.A., Golubev S.A., Kozarenko L.A., Plotnikov D.V. Gender differences in the structure of cerebral indices of the background EEG of a human, Kursk scientific and practical journal "Man and his health". 2011. N 2. Р. 5-8.]
  48. Nusslock R., Walden K., Harmon-Jones E. Asymmetrical frontal cortical activity associated with differential risk for mood and anxiety disorder symptoms: An RDoC perspective // Int. J. Psychophysiol. 2015. Vol. 98, N 2. P. 249-261.


Abstract - 189

PDF (Russian) - 0




  • There are currently no refbacks.

Copyright (c) 2018 Shamaeva T.F.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies